Flputnam Investment Management Co. Grows Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Flputnam Investment Management Co. boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 86.1% in the fourth quarter, HoldingsChannel reports. The fund owned 40,113 shares of the exchange traded fund’s stock after acquiring an additional 18,555 shares during the period. Flputnam Investment Management Co.’s holdings in SPDR S&P Biotech ETF were worth $3,613,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Tidemark LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. bought a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $40,000. Finally, Bank of Jackson Hole Trust purchased a new position in SPDR S&P Biotech ETF during the fourth quarter valued at $43,000.

SPDR S&P Biotech ETF Trading Up 1.8 %

SPDR S&P Biotech ETF stock opened at $88.71 on Friday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company has a market capitalization of $5.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The business’s fifty day simple moving average is $91.00 and its two-hundred day simple moving average is $95.75.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.